Overview
Capricorn Partners is a Leuven-based Venture Capital firm with over 30 years of history and more than EUR 300M in assets under management. The firm employs 20 investment professionals and operates across four focus areas: cleantech, digital, health, and fusion technology.
The fund has a strong track record of Belgian portfolio companies and participates in both early and growth-stage rounds. Its Leuven base gives it proximity to the KU Leuven research and spin-off ecosystem.
Portfolio
- StoryChief - Content marketing platform
- icometrix - Medical imaging AI
- Conxai - Agentic AI for construction automation
Investments
icometrix
icometrix was a Leuven-based medtech company providing AI-powered brain MRI analytics software, acquired by GE HealthCare in September 2025.
StoryChief
StoryChief is a Ghent-based AI-powered content marketing platform used by 5,000 customers across 70 countries to plan, create, and distribute content across multiple channels from a single workspace.
Bingli
Bingli is an Antwerp-based AI patient anamnesis platform with EUR 5.4M in Series A funding from Capricorn Partners and UCB, automating the pre-consultation intake process for physicians.
Conxai
Conxai develops AI solutions designed to augment human expertise in construction workflows.
In the news
- We're proud to share that Hybrid Core has been selected as a finalist for the Startup World Cup Brussels 🇧🇪. Thank you to Startup&Angels for putting together such a strong finalist lineup, and to co-hosts Le Village by CA Brussels and BeCentral for building the room where this happens. On 30 September, we'll pitch in front of an investor-led jury at Degroof Petercam in Brussels — one step on the way to representing Belgium at the Global Grand Finale in San Francisco. Congratulations to the fellow finalists we'll share the stage
- European buyers have been offered a false choice: AI that adapts to how you actually work, or AI that stays inside your walls. Not both. Cloud AI vendors are adaptive but not sovereign. Traditional defence primes are sovereign but not adaptive. The intersection has been empty — and it is exactly where ministries, banks and grid operators need to buy. Hybrid Core's Smart Navigator now runs Operationalised AI across all seven modules. Not AI as architecture. AI as a capability the user touches: ▪ Ontology-bound reasoning — generate
- Twenty-six EDF calls close on 29 September. Twenty-six consortia will each build something good. How many of those will talk to each other afterward? That's the question I can't stop asking while reading this year's Work Programme. The Fund rightly insists on European-controlled IP and multi-country consortia — but nothing in a single-topic grant obliges the quantum-networking project and the AI-situational-awareness project to share a data model once both are done. The article is about why I think the composing layer, not the
- Innovation starts with great science. Impact requires #funding. 💶 👩🏽⚕️🦠Across #healthcare and life sciences, researchers, startups and scale-ups are under increasing pressure. Developing new therapies, #diagnostics, medical devices and digital health solutions takes time, expertise and substantial investment. 👉 Yet many innovators point to the same challenge: access to funding remains one of the biggest barriers between promising research and real-world impact. 🎯 That's why our CEO, Ann Van Gysel, has always put so much
- Regulation (EU) 2026/1744 entered into force on 27 July. High-risk obligations under Annex III of the AI Act now apply from 2 December 2027 rather than 2 August 2026. Our new article argues that the deferral moved one clock and left two running. Procurement in critical sectors still takes twelve to twenty-four months. Cryptographic exposure has no omnibus at all. Smart Navigator was built for buyers, not deadlines: seven integrated modules, explainability as architecture, post-quantum embedded at design time, running inside the
- We welcome Peter-William to the Capricorn Health team as our new Investment Associate! Peter-William Hellings brings a unique combination of medical expertise, biomedical engineering, and hands-on healthtech entrepreneurship to the team. Some of you may already know him — Peter-William did an internship at Capricorn Partners a year ago, and we're thrilled he decided to come back again! And as a bonus… the team now has its very own trail guide ready to lead the next multi-day mountain hike Katrin Geyskens Filip Pintelon
- Just one week after announcing our investment in Endo Tools Therapeutics, the company is already taking another important step forward. 👏 We are excited to welcome Devon Bream as CEO. With more than 25 years of leadership experience in medtech and endoscopy, Devon brings the commercial expertise needed to accelerate Endo Tools Therapeutics in U.S. following its recent FDA 510(k) clearance 🇺🇸. 🙏 A big thank you to Alexandre Chau for his leadership in bringing the company to this stage and realize the funding round with us. In
- New investment in healthtech! Capricorn Partners, via our Capricorn Healthtech Fund II, has co-led a €20M Series C round for Endo Tools Therapeutics, together with MGFO, and joined by existing investors. 🩺 Endo Tools lets doctors treat obesity and other gastrointestinal conditions through a minimally invasive procedure instead of open surgery. Its endomina® platform attaches to a standard endoscope, letting physicians stitch and reshape tissue from inside the stomach, through the mouth, no incisions needed. 📈 The funding will
Alumni 1 went on to found or lead
Peter-William HellingsVisiting Analyst→Chief Executive Officer at MedEx
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.